Interpace Biosciences, Inc.
IDXG· OTC
IDXGInterpace Biosciences, Inc.
Filed Mar 30, 2016 · 10-K · 90 days after period end · 0001054102-16-000097
derived · Computed from the longer spans the company filed.
| Metric | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $28.83M | $32.11M | $35.63M |
| Net Income | $3.88M | -$8.04M | -$3.67M | -$23.80M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Interpace Biosciences, Inc. · CIK 1054102 · Engraved from SEC EDGAR
ended Dec 31, 2015 · filed Mar 30, 2016 · 90 d after period end
